Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1)
|
|
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1) Eigenschaften
Sicherheit
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1) Chemische Eigenschaften,Einsatz,Produktion Methoden
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-Methoxyphenyl)-1-piperazinyl]-3-[2-Methoxy-5-(trifluoroMethyl)phenyl]-, Methyl ester
[S(R*,R*)]-2,3-Bis[(4-methylbenzoyl)oxy]bernsteinsure
Downstream Produkte
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 18)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
ANHUI WITOP BIOTECH CO., LTD | +8615255079626 |
eric@witopchemical.com | China | 23541 | 58 |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 |
masar@topule.com | China | 8467 | 58 |
CHENGHUI PHARMACEUTICAL GROUP LTD | 0531-58897070 15254140813 |
market@jnchsd.com | China | 213 | 58 |
Jinan Chenghui Shuangda biological Co., LTD | 0531-58897003 15550412551 |
market@jnchsd.com | China | 211 | 62 |
ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 |
2853530910@QQ.com | China | 8011 | 62 |
Lynnchem | 86-(0)29-85992781 17792393971 |
info@lynnchem.com | China | 4587 | 58 |
Novachemistry | 44-20819178-90 02081917890 |
info@novachemistry.com | United Kingdom | 4381 | 58 |
Shanghai Yu Ben Biotechnology Co., Ltd. | 15502154572 |
yuben012@sina.com | China | 508 | 58 |
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd. | 0531-58897130 15508676053 |
drug_impurity@sdcclh.com | China | 1976 | 58 |
Wuhan Chujiang Haoyu Chemical Technology Development Co., Ltd. | 18171284407 |
1850853183@qq.com | China | 307 | 58 |
- Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1)
- (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]succinic acid {(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-(trifluormethyl)phenyl)-3,4-dihydroquinazolin-4-yl}acetic acid methyl ester
- ORBOVPDSXOKTQB-GDGVXITASA-N
- Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-me
- LeterMovir-004-salt
- Mupiravir intermediate
- Letermovir Impurity 33
- 917389-30-1